FY2021 · ended Dec 31, 2021 · Revenue $12,630, -73.7% YoY · Filed Apr 13, 2023
Trafalgar International, Inc. (TRFA) files with the SEC under industry code 2834, Pharmaceutical Preparations.
Revenue
$12,630
-73.7% vs prior year
Net income
$-331,612
-85.2% vs prior year
Operating cash flow (TTM)
$-40,701
+24.1% vs year-ago TTM
Free cash flow
—
EPS
$0.00
Dividend per share
None
Shares outstanding
944,935
-99.9% vs prior year
Net cash
—
Operating margin
-2716.9%
FY 2021
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TRFA (OTC), GCAND
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Miami, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1695473
- Former names
- Greater Cannabis Company, Inc. (until Jul 31, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | $12,630 |
| Operating income | -$183,005 | -$156,276 | -$175,364 | -$177,035 | -$343,146 |
| Net income | -$331,612 | -$179,041 | -$188,402 | -$360,268 | -$602,226 |
| Diluted EPS | $0.00 | $0.00 | $0.00 | — | — |
| Operating cash flow | -$60,153 | -$109,491 | -$103,171 | -$107,490 | -$235,433 |
| Total assets | $815 | $57,785 | $172,276 | $280,447 | $392,937 |
| Total liabilities | $742,464 | $898,058 | $833,508 | $825,277 | $861,999 |
| Stockholders' equity | -$741,649 | -$840,273 | -$661,232 | -$544,830 | -$469,062 |
| Cash and investments | $815 | $57,368 | — | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Oct 14, 2026 | Oct 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 21, 2026 | Sep 18, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Other events
|
Jul 31, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Material agreement, Change in control, Officer or director change
|
Jul 6, 2026 | Jun 29, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
All 143 Trafalgar International, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.